Women's Health Clinical Trials
Here are the 6 most popular medical studies in Women's Health Clinical Trials
mTORC1/2 Inhibitor
mTOR/AKT Inhibitors for Endometrial and Ovarian Cancer
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing the side effects and best dose of two different drug combinations in treating patients with recurrent endometrial, triple negative breast cancer, ovarian, primary peritoneal, or fallopian tube cancer.
Parental Support Package for Pregnant Trainees' Wellbeing
Recruiting1 award
Boston, Massachusetts
This trial aims to investigate the effects of a support package for medical trainee mothers, including mentorship, breastfeeding and sleep aids, and access to perinatal care, to improve their wellbeing and reduce medical errors.
Vessel Sealing Device
Vessel Sealing Device vs Conventional Suturing for Pelvic Organ Prolapse
Recruiting1 award5 criteria
Cincinnati, Ohio
This trial will compare pain outcomes for patients undergoing vaginal hysterectomy with pelvic reconstructive surgery using a new vessel sealing device as compared to conventional methods.
Popular filter options for Women's Health Clinical Trials trials
Phase 3 Clinical Trials
View 98 phase 3 medical studies.
PARP Inhibitor
Olaparib vs. Cediranib + Olaparib for Recurrent Ovarian Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial is comparing two different treatments for ovarian, fallopian tube, or primary peritoneal cancer that has come back. One treatment is a standard chemotherapy treatment, and the other is a new treatment that uses two drugs, olaparib and cediranib maleate. The trial will see if the new treatment is more effective than the standard chemotherapy treatment.
Behavioral Intervention
Integrated e-Health for Substance Use Disorders and HIV/AIDS
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial will test if an online decision aid and eHealth program can help reduce stigma and improve PrEP and opioid use disorder care for women involved in the criminal justice system.
Clinical Trials With No Placebo
View 98 medical studies that do not have a placebo group.
PARP Inhibitor
Olaparib vs. Cediranib + Olaparib for Recurrent Ovarian Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial is comparing two different treatments for ovarian, fallopian tube, or primary peritoneal cancer that has come back. One treatment is a standard chemotherapy treatment, and the other is a new treatment that uses two drugs, olaparib and cediranib maleate. The trial will see if the new treatment is more effective than the standard chemotherapy treatment.
View More Women's Health Clinical Trials Trials
See another 81 medical studies focused on Women's Health Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.